bosentan anhydrous has been researched along with Limited Scleroderma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bootsma, H; Hettema, ME; Kallenberg, CG; Smit, AJ; Stienstra, Y; Zhang, D | 1 |
| Weinerth, J; Wiesent, F | 1 |
| Hall, FC; Ostor, AJ; Yu, EP | 1 |
1 trial(s) available for bosentan anhydrous and Limited Scleroderma
| Article | Year |
|---|---|
No effects of bosentan on microvasculature in patients with limited cutaneous systemic sclerosis.
Topics: Adult; Aged; Antihypertensive Agents; Bosentan; Drug Therapy, Combination; Endothelium, Vascular; Female; Humans; Immunosuppressive Agents; Laser-Doppler Flowmetry; Male; Microcirculation; Microscopic Angioscopy; Middle Aged; Nails; Outpatients; Pilot Projects; Raynaud Disease; Regional Blood Flow; Scleroderma, Limited; Sulfonamides; Treatment Outcome; Vasodilation | 2009 |
2 other study(ies) available for bosentan anhydrous and Limited Scleroderma
| Article | Year |
|---|---|
[Digital ulcers in systemic sclerosis--an interdisciplinary challenge].
Topics: Angiography; Antihypertensive Agents; Arm; Bosentan; Cooperative Behavior; CREST Syndrome; Endothelin Receptor Antagonists; Fatal Outcome; Fingers; Follow-Up Studies; Hand Dermatoses; Humans; Iloprost; Interdisciplinary Communication; Leg; Male; Middle Aged; Scleroderma, Limited; Skin Ulcer; Sulfonamides; Vasodilator Agents | 2010 |
Successful treatment with bosentan for severe digital ischaemia in limited cutaneous systemic sclerosis.
Topics: Adult; Bosentan; Fingers; Humans; Ischemia; Male; Scleroderma, Limited; Sulfonamides; Vasodilator Agents | 2007 |